Phenex develops novel proprietary small molecule drugs targeting nuclear receptors.
Business Model:
Revenue: $39M
Employees: 51-200
Phenex was acquired by
Gilead Sciences.
The acquisition happend on 2015-01-06.
Details of the transaction were not public
Address: Waldhofer Str. 104
City: Heidelberg
State: baden-württemberg
Zip: 69123
Country: DE
Phenex develops novel proprietary small molecule drugs targeting nuclear receptors.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2005 | Series A | $5.7M |
KfW Mittelstandsbank |
7/2009 | Grant | $2M | 10/2005 | Series A | 2 | $5M |
Rheinland-Pfalz Fonds KfW Rheinland-Pfalz Fonds |
9/2010 | Series C | $0 |
KfW CD-Venture EVP Capital Management Swiss Life Private Equity Partners Creathor Ventures LBBW VC KfW CD-Venture EVP Capital Management Swiss Life Private Equity Partners Creathor Ventures LBBW VC |
10/2008 | Series B | 4 | $11.4M |
LBBW VC Creathor Ventures KfW EVP Capital Management LBBW VC Creathor Ventures KfW |
9/2010 | Series C | $7.8M |
Creathor Venture Management LBBW Venture EVP Capital Management CD-Venture |
1/2009 | Venture Round | 1 | - |
COI Partners COI Partners |
10/2012 | Series D | $6.5M | 9/2010 | Series C | 6 | $7.9M |
KfW CD-Venture EVP Capital Management Swiss Life Private Equity Partners Creathor Ventures LBBW VC KfW CD-Venture EVP Capital Management Swiss Life Private Equity Partners Creathor Ventures LBBW VC |
1/2009 | Venture Round | 1 | - |
COI Partners COI Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|